Aspen Aerogels (NYSE:ASPN) Trading Down 4.3%

Aspen Aerogels, Inc. (NYSE:ASPN) shares traded down 4.3% on Friday . The stock traded as low as $27.50 and last traded at $27.53. 267,211 shares were traded during trading, a decline of 79% from the average session volume of 1,299,470 shares. The stock had previously closed at $28.76.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. HC Wainwright raised their target price on Aspen Aerogels from $25.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Piper Sandler boosted their target price on Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a research report on Wednesday, May 29th. B. Riley raised Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, June 25th. Craig Hallum boosted their target price on Aspen Aerogels from $33.00 to $38.00 and gave the company a “buy” rating in a research report on Friday, June 14th. Finally, Barclays started coverage on Aspen Aerogels in a research report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 target price on the stock. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $29.70.

Aspen Aerogels Stock Down 4.6 %

The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. The company has a market cap of $2.09 billion, a price-to-earnings ratio of -65.36 and a beta of 2.16. The firm’s 50 day simple moving average is $24.90 and its 200-day simple moving average is $23.13.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The company had revenue of $117.80 million during the quarter, compared to the consensus estimate of $101.99 million. During the same quarter in the prior year, the firm posted ($0.22) earnings per share. Aspen Aerogels’s revenue for the quarter was up 144.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Aspen Aerogels, Inc. will post 0.21 earnings per share for the current year.

Insider Transactions at Aspen Aerogels

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 4.30% of the company’s stock.

Hedge Funds Weigh In On Aspen Aerogels

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. AIGH Capital Management LLC grew its stake in Aspen Aerogels by 3.0% in the 4th quarter. AIGH Capital Management LLC now owns 1,804,484 shares of the construction company’s stock valued at $28,475,000 after acquiring an additional 52,462 shares during the last quarter. Banque Cantonale Vaudoise grew its stake in Aspen Aerogels by 37.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after acquiring an additional 1,252 shares during the last quarter. Harbour Capital Advisors LLC acquired a new stake in Aspen Aerogels in the 1st quarter valued at about $404,000. Bridgewater Advisors Inc. acquired a new stake in Aspen Aerogels in the 1st quarter valued at about $750,000. Finally, BNP Paribas Financial Markets grew its stake in Aspen Aerogels by 85.2% in the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock valued at $452,000 after acquiring an additional 11,823 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.